Drug Shortage Report for TEVA-VENLAFAXINE XR
| Report ID | 113803 |
| Drug Identification Number | 02275023 |
| Brand name | TEVA-VENLAFAXINE XR |
| Common or Proper name | VENLAFAXINE XR 37.5MG CAP |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 37.5MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-29 |
| Estimated end date | Unknown |
| Actual end date | 2020-06-08 |
| Shortage status | Resolved |
| Updated date | 2020-06-11 |
| Company comments | Product is discontinued, and transitioned to the ACT product. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-06-11 | French | Compare |
| v3 | 2020-06-11 | English | Compare |
| v2 | 2020-05-01 | French | Compare |
| v1 | 2020-05-01 | English | Compare |
Showing 1 to 4 of 4